Page last updated: 2024-08-23

zidovudine and Epstein-Barr Virus Infections

zidovudine has been researched along with Epstein-Barr Virus Infections in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's8 (66.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drosu, NC; Edelman, ER; Housman, DE1
Ashlock, B; Bayraktar, S; Bayraktar, UD; Cabral, L; Diaz, LA; Dittmer, DP; Pereira, D; Ramos, JC; Toomey, N1
Shah, I1
Baiocchi, RA; Barth, RF; Bhatt, D; Caligiuri, MA; Eisenbeis, CF; Ferketich, A; Grecula, J; Gupta, N; Moeschberger, M; Nuovo, GJ; Peng, R; Porcu, P; Roychowdhury, S; Schmalbrock, P; Vourganti, S; Yang, W1
Feuer, G; Harrington, W; Rochford, R; Toomey, L; Wu, W1
Barber, GN; Cabral, L; Dittmer, DP; Ghosh, SK; Harrington, WJ; Kurokawa, M; Mian, AM; Ramos, JC; Toomey, NL; Whitby, D1
Andela, V; Barreto, JE; Ghosh, S; Harrington, W; Kurokawa, M1
Li, xQ; Zhu, XZ1
Blackstock, W; Feng, W; Israel, B; Kenney, SC; Westphal, EM1
Carr, A; Cooper, DA; Cunningham, PH; Goh, LE; Grey, P; Kaufmann, GR; Smith, D; Suzuki, K; Zaunders, JJ1
Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C1

Reviews

1 review(s) available for zidovudine and Epstein-Barr Virus Infections

ArticleYear
Zidovudine: a targeted therapy for endemic Burkitt's lymphoma.
    East African medical journal, 2005, Volume: 82, Issue:9 Suppl

    Topics: Africa; Antiviral Agents; Brazil; Burkitt Lymphoma; Developing Countries; Drug Delivery Systems; Epstein-Barr Virus Infections; Gene Targeting; Herpesvirus 4, Human; Humans; Oncogenes; Zidovudine

2005

Other Studies

11 other study(ies) available for zidovudine and Epstein-Barr Virus Infections

ArticleYear
Could antiretrovirals be treating EBV in MS? A case report.
    Multiple sclerosis and related disorders, 2018, Volume: 22

    Topics: Adult; Brain; Drug Combinations; Epstein-Barr Virus Infections; Fatigue; Female; Humans; Immunologic Factors; Lamivudine; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors; Zidovudine

2018
Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell Line, Tumor; Combined Modality Therapy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine

2014
Response to valacyclovir in an HIV-infected girl with Epstein Barr infection.
    Indian pediatrics, 2012, Volume: 49, Issue:5

    Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine

2012
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
    Cancer research, 2003, Mar-01, Volume: 63, Issue:5

    Topics: Animals; Antiviral Agents; Brain Neoplasms; Combined Modality Therapy; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Kidney Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Rats; RNA, Messenger; Thymidine Kinase; Up-Regulation; Xenograft Model Antitumor Assays; Zidovudine

2003
Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
    Leukemia research, 2005, Volume: 29, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Interferon-alpha; Lymphoma, B-Cell; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Reverse Transcriptase Inhibitors; Survival Rate; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Zidovudine

2005
Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
    Blood, 2005, Jul-01, Volume: 106, Issue:1

    Topics: Apoptosis; Burkitt Lymphoma; Epstein-Barr Virus Infections; Gene Expression Profiling; Gene Expression Regulation, Viral; Genome, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; NF-kappa B; Phosphorylation; Reverse Transcriptase Inhibitors; Transcription Factor RelA; Tumor Cells, Cultured; Zidovudine

2005
[Comment on pathology research of malignant lymphoma].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2006, Volume: 35, Issue:4

    Topics: Antiviral Agents; Common Variable Immunodeficiency; Epstein-Barr Virus Infections; Humans; Interferon-alpha; Lymphoma; Pathology, Clinical; Prognosis; Zidovudine

2006
Drug combination treats brain cancer.
    AIDS patient care and STDs, 1999, Volume: 13, Issue:12

    Topics: Anti-HIV Agents; Brain Neoplasms; CD4 Lymphocyte Count; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; HIV Infections; Humans; Interleukin-2; Lymphoma, AIDS-Related; Radiotherapy, Adjuvant; Treatment Outcome; Zidovudine

1999
Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Cancer research, 2000, Oct-15, Volume: 60, Issue:20

    Topics: Animals; Antiviral Agents; B-Lymphocytes; Biotransformation; Burkitt Lymphoma; Butyrates; Cell Death; Cell Line, Transformed; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Lymphocytes; Mice; Mice, SCID; Neoplasms, Experimental; Stomach Neoplasms; Tumor Virus Infections; Virus Activation; Xenograft Model Antitumor Assays; Zidovudine

2000
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5

    Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Epstein-Barr Virus Infections; Flow Cytometry; Furans; Genotype; HIV Infections; HIV-1; Humans; Immunoglobulin M; Lamivudine; Longitudinal Studies; Male; Proto-Oncogene Proteins c-bcl-2; Receptors, CCR5; Sulfonamides; Time Factors; Zidovudine

2001
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Oncogene, 2001, Oct-25, Volume: 20, Issue:48

    Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine

2001
chemdatabank.com